Status:

RECRUITING

inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT

Lead Sponsor:

Leiden University Medical Center

Conditions:

Venous Thromboembolism

Venous Thromboses

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

After hip or knee replacement all patients receive a standardized treatment with blood thinners, this medication is called thrombosis prophylaxis. However, despite this standard treatment some individ...

Detailed Description

Background Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are associated with an overall symptomatic venous thromboembolism (VTE) risk of about 1.3% despite the use of prophylactic an...

Eligibility Criteria

Inclusion

  • Scheduled to undergo an elective total hip arthroplasty or total knee arthroplasty
  • Aged 18 years or older

Exclusion

  • Primary arthroplasty for fractures
  • Revision surgery
  • Hemiarthroplasty
  • Pregnancy
  • Current use of therapeutic anticoagulant therapy of any type (e.g., LMWH, DOAC, vitamin K antagonist)
  • A contraindication for either study drug
  • Insufficient knowledge of the Dutch language
  • Insufficient mental or physical ability to fulfil trial requirements
  • Active malignancy (i.e. cancer diagnosis within six months before surgery (excluding basal-cell or squamous-cell carcinoma of the skin), recently recurrent or progressive cancer or any cancer that required anti-cancer treatment within six months before surgery)
  • Patients using thrombocyte aggregation inhibitors that cannot be temporarily discontinued at the discretion of their treating physician

Key Trial Info

Start Date :

November 11 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2031

Estimated Enrollment :

10078 Patients enrolled

Trial Details

Trial ID

NCT06581965

Start Date

November 11 2024

End Date

February 1 2031

Last Update

September 3 2025

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Gelre Ziekenhuizen

Apeldoorn, Gelderland, Netherlands, 7334 DZ

2

Zuyderland

Geleen, Limburg, Netherlands, 6162 BG

3

Anna Ziekenhuis

Geldrop, North Brabant, Netherlands, 5564EH

4

Bravis ziekenhuis

Roosendaal, North Brabant, Netherlands, 4708 AE

inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT | DecenTrialz